Tetra starts Phase ll Trial of BPN14770 for Fragile X Syndrome
Tetra Discovery Partners has commenced a Phase ll trial of BPN14770 for the treatment of Fragile X Syndrome, the most…
Tetra Discovery Partners has commenced a Phase ll trial of BPN14770 for the treatment of Fragile X Syndrome, the most…